Molecular changes during extended endocrine treatment of breast cancer

ABSTRACT: Sequential patient-matched samples treated with extended neoadjuvant therapy were studied. Samples were classified as pre-treatment (timepoint1, <0 days), early-on treatment (timepoint2, 0-120 days) and long-term treatment (timepoint4, >120 days).

OTHER RELATED OMICS DATASETS IN: GSE111563

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Breast Cancer Cell

DISEASE(S): Breast Cancer

SUBMITTER: Cigdem Selli  

LAB HEAD: Andrew H Sims

PROVIDER: PXD009328 | Pride | 2019-02-27

REPOSITORIES: Pride